Odronextamab (REGN1979), a Human CD20 x CD3 Bispecific Antibody, Induces Durable, Complete Responses in Patients with Highly Refractory B-Cell Non-Hodgkin Lymphoma, Including Patients Refractory to CAR T TherapyRajat Bannerji, Max S. Topp, Jon Arnason et al.|Blood|2020Cited by 108